Abstract: New organometallic complexes having bis- or tris-heteroleptic ligands and large aspect ratio in one direction and their use in OLEDs to enhance the efficiency is disclosed.

Abstract: A novel compound having a first ligand LA of is disclosed. The compound is useful as emitter dopant in OLEDs.

Abstract: A metal tetradentate complex is disclosed in which an imidazole moiety is used as a linker in the ligand. The complex is useful as an emitter or other functional roles in an OLED device.

Abstract: Metal complexes with ligands bearing a five member aromatic moiety fused with dibenzofuran or its analogues useful as electroluminescence materials in OLEDs are disclosed.

Abstract: Provided is an organometallic compound including a first ligand LA selected from In ligand LA, each of Y1 to Y10 is carbon or nitrogen; moiety B is a monocyclic or polycyclic fused ring structure including 5-membered and/or 6-membered rings; any two RA and RB can be fused or joined to form a ring; X is selected from O, S, Se, or NR; each RA and RB is independently hydrogen or a substituent selected from the general substituent defined herein; at least one R, RA, or RB is deuterium or a linking group between LA and another ligand that includes a deuterium substituted aromatic ring; and LA is coordinated to a metal M, selected from Os, Pd, Pt, Ir, Cu, Ag, or Au; and the compound is capable of emitting light with a peak maximum wavelength (?max)?700 nm at room temperature.

Abstract: Metal complexes with cyclic ligands having Formula (I), are disclosed. Ligands with cyclic structure are believed to be beneficial to the rigidity and stability of the metal complexes, which is desirable for improving OLED device performance.

Abstract: Provided are organometallic compounds comprising a first ligand LA comprising a multicyclic fused ring system wherein ligand LA is coordinated to a metal M; and wherein M is selected from the group consisting of Os, Ir, Pd, Pt, Cu, Ag, and Au. Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.

Abstract: According to an aspect of the present disclosure, a compound having a metal planar tetradentate coordination configuration is disclosed. In the compounds, the metal M is Pt or Pd; the four coordinating atoms are Z1, Z2, Z3, and Z4 and are each selected from N, C, and O. The compound includes a substituent R, and atoms M, Z1, Z2, Z3, and Z4 are used to define a first plane that passes through the metal M and is positioned to have a minimum sum of shortest distances with Z1, Z2, Z3, and Z4. At least one non-hydrogen atom in R falls within a distal circle of a cylinder extending perpendicular to the first plane, where the distal circle of the cylinder is a height h from the base circle and the height h ranges from 3.3 ? to 4.8 ?.

Abstract: A compound having a first ligand LA of Formula I shown below is disclosed.

Abstract: A compound including a first ligand LA of Formula I is disclosed. In the structure of Formula I, one of L1 and L2 is C, and the other is N; Y1 to Y14 are each C or N; at least two adjacent Y7, Y8, Y9, and Y10 are carbon atoms that are fused to a structure of Formula II Z1 and Z2 are each O, S, Se, NR, CRR?, or SiRR?; and each R, R?, RA, RB, RC, and RD is hydrogen or a substituent; and any two substituents may be joined or fused together to form a ring. In the compound, LA is complexed to a metal M by L1 and L2, and M has an atomic weight greater than 40. Organic light emitting devices and consumer products containing the compounds are also disclosed.

Abstract: Metal complexes with ligands bearing a five member aromatic moiety fused with dibenzofuran or its analogues useful as electroluminescence materials in OLEDs are disclosed.

Abstract: A ligand for metal complexes are disclosed, in which an imidazole ring is fused to an aromatic ring as a substituent or an imidazole ring is fused to a six-member ring of the original ligand. The features of these elements within the ligand afford a better device performance in general OLED device.

Abstract: A neutral compound including a first ligand LA represented by Formula I or Formula II is disclosed.

Abstract: A metal compound including a first ligand LA having the Formula: Formula I, is disclosed. The metal compounds are useful in the emissive layer in organic light emitting devices.

Abstract: A compound including a first ligand LA of Formula I, is disclosed. In Formula I, ring B is a 5- or 6-membered ring; X1, X2, and X3 are each CRA or N; R is a 5- or 6-membered carbocyclic or heterocyclic ring, which can be further fused or substituted; and (1) when ring B is an unfused 6-membered ring, X1 and X2 are N, and X3 is C; and (2) when ring B is a fused 6-membered ring, ring B has the structure of Formula II, In this structure, the wavy line indicates the point of connection to ring A; Q1 to Q6 are each C or N; and, when proviso (2) applies, (I) at least one of X1, X2, and X3 is N; or (II) R is two or more fused or unfused 5- or 6-membered carbocyclic or heterocyclic rings, or (III) at least ring A or R is substituted with a partially or fully deuterated alkyl or partially or fully deuterated cycloalkyl group.

Abstract: Novel organic metal complexes containing fused isoquinoline type ligands useful as emitters for near infrared OLED devices are disclosed.

Abstract: A compound including a first ligand LA having a structure of Formula I is disclosed. The compound is useful a an emitter dopants in OLEDs for enhancing the OLED performance.

Abstract: Provided are novel silyl-containing acetylacetonate derivatives compounds. Also provided are formulations comprising these silyl-containing acetylacetonate derivatives compounds. Further provided are OLEDs and related consumer products that utilize these silyl-containing acetylacetonate derivatives compounds.

Abstract: Provided is an OLED having an anode, a cathode and an organic emissive layer disposed between the anode and the cathode.

Abstract: A novel compound is disclosed which includes a ligand LA of Formula II, wherein: ring B is independently a 5-membered or 6-membered carbocyclic or heterocyclic ring; X1 to X4 are each independently selected from the group consisting of C, N, and CR; at least one pair of adjacent X1 to X4 are each C and fused to Formula V ?where indicated by “”; X5 to X12 are each independently C or N; the maximum number of N within a ring is two; Z and Y are each independently selected from the group consisting of O, S, Se, NR?, CR?R?, SiR?R?, and GeR?R?; RB and RC each independently represents zero, mono, or up to a maximum allowed substitutions to its associated ring; each of RB, RC, R, R?, and R? is independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile,